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Abstract
Human genome resequencing technologies are becoming ever more affordable and provide a valuable source of
data about rare genetic variants in the human genome. Such rare variation may play an important role in
explaining the missing heritability of complex human traits. We implement an existing method for analyzing rare
variants by testing for association with the mutational load across genes. In this study, we make use of simulated
data from the Genetic Analysis Workshop 17 to assess the power of this approach to detect association with
simulated quantitative and dichotomous phenotypes and to evaluate the impact of missing genotypes on the
power of the analysis. According to our results, the mutational load based rare variant analysis method is relatively
robust to call-rate and is adequately powered for genome-wide association analysis.
Background
The success of genome-wide association studies
(GWAS) to identify novel loci that contribute to com-
plex human traits has been well publicized [1]. However,
despite these successes, much of the genetic component
of these traits remains unexplained. Most genotyping
products that are used in GWAS have been designed to
capture common human genetic variation [2], and with
ever increasing sample sizes and meta-analysis, we
might expect to identify associations with common var-
iants with ever decreasing effect size. However, it seems
unlikely that the common disease/common variant
model will entirely explain the missing heritability of
complex traits. One widely unexplored paradigm that
m a yc o n t r i b u t et ot h i su n e x p l a i n e dg e n e t i cc o m p o n e n t
is a model of multiple rare causal variants, defined here
as those having a minor allele frequency (MAF) less
than 5%, each with modest effect but residing within the
same gene. Such an association has recently been identi-
fied between rare variants in the IFIH1 gene and type 1
diabetes [3].
Until recently, the availability of data appropriate for
rare variant association analysis has been extremely lim-
ited. However, with improvements in the efficiency of
deep resequencing technologies, discovery and analysis
of rare variants is becoming increasingly cost-effective
and financially feasible in large disease- or population-
based cohorts at the level of specific genes or even
exome-wide. Furthermore, large-scale whole-genome
resequencing efforts, such as the 1000 Genomes Project
[4], continue to make their data available to the research
community. These resources are likely to provide near
complete catalogs of low-frequency genetic variation
and of many other rarer variants in a variety of popula-
tions across ethnic groups. These data can provide deep
and high-density reference panels, potentially allowing
for imputation of rare variants that are not typically
directly assayed or otherwise captured by genotyping
products in GWAS [5].
One common approach to the joint analysis of rare
variants within the same gene is to focus on their muta-
tional load, searching for accumulations of minor alleles
across individuals with the same or similar phenotype
[6,7]. Simulation studies have demonstrated that such
an approach has much greater power to detect rare var-
iant associations than traditional single-SNP analyses
[6,7]. However, these studies typically assume no
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larly for rare variants, may affect the results of their
downstream analysis. In this study, we undertake simu-
lations to assess the effects of missing genotype data on
rare variant association analysis. We use the simulated
data from Genetic Analysis Workshop 17 (GAW17),
which includes genotypes at exonic rare variants within
a subset of genes across the genome, generated from the
1000 Genomes Project [4]. We make use of a simple
model of random missing genotypes and evaluate the
effect of failure rate on the power of mutational load
rare variant association with quantitative and dichoto-
mous traits. Analysis of pilot data from the 1000 Gen-
omes Project shows that the mutant (rare) allele is more
difficult to call than the reference (common) allele. To
mimic this allele-specific failure rate, we have incorpo-
rated into our analysis a more complex model of miss-
ing data in which the call rate is determined by the
underlying genotype.
Methods
Rare variant mutational load analysis
Consider a sample of unrelated individuals typed for
rare variants within the same gene. Let ni denote the
number of rare variants for which the ith individual has
been successfully genotyped, and let ri denote the num-
ber of these variants for which the individual carries at
least one copy of the minor allele. We can model the
phenotype yi of the ith individual in a generalized linear
modeling (GLM) framework, given by:
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where g is the link function, xi denotes a vector of
covariate measurements for the ith individual with cor-
responding regression coefficients b, and parameter l is
the expected increase in the phenotype for an individual
carrying a full complement of minor alleles at rare var-
iants compared to an individual carrying none. Thus we
construct a likelihood ratio test of association of the
mutational load of rare variants with disease by compar-
ing the maximized likelihoods of two models by means
of analysis of deviance: (1) the null model where l =0
and (2) the alternative model where l is unconstrained.
The contribution of the ith individual to the likelihood
is weighted by ni to allow for differential call rates
between samples.
The described method has been implemented using
t h eG R A N V I Ls o f t w a r e ,w h i c hi sf r e e l ya v a i l a b l ef o r
download from http://www.well.ox.ac.uk/GRANVIL.
The software can be applied to quantitative traits and
dichotomous phenotypes and can adjust for potential
confounders as covariates. Users must provide a list of
genes, with start and stop positions, together with a
map file for variant locations.
GAW17 data
The data provided by GAW17 contain genotype data for
697 individuals from the 1000 Genomes Project [4]. Indi-
viduals were chosen from different populations with Eur-
opean, Asian, and African origin. Overall, 24,487 variants
from 3,205 gene regions were provided with MAFs in the
range 0.07–16.6%. Three normally distributed quantitative
traits and a dichotomous disease phenotype were simu-
lated for each individual on the basis of their genotype
data. Q1 and Q2 phenotypes were determined by geno-
types in 9 and 13 genes, respectively. Q4 was not deter-
mined by any variants among the genes provided. Disease
liability was generated using a function of Q1, Q2, and Q4
phenotypes in addition to variants in a further 15 genes.
Two hundred replicates of data were simulated, each on
the basis of the same underlying genotypes and each
stored in a separate phenotype file. Full details of the
GAW17 data and simulation approach used to generate
the phenotype data are reported elsewhere [8].
Simulation study
We make use of the simulated GAW17 data to investi-
gate the type I error rate and power of GRANVIL to
detect association with quantitative traits Q1, Q2, and
Q4 and the dichotomous disease (CC) phenotype. We
consider rare variants to have MAF < 5%. GRANVIL
gives equal weight to all these rare variants in the gene,
irrespective of their potential functional role. We there-
fore performed two analyses of each replicate of pheno-
type data: (1) including all rare variants, irrespective of
function; and (2) restricting rare variants to those that
are nonsynonymous. We used GRANVIL to test for
association with the mutational load in each gene con-
taining at least two rare variants. Phenotype data for
individual NA07347 was excluded because of extreme
deviation from the mean in most replicates [9]. For each
analysis, all phenotypes were adjusted for sex, age, and
smoking status. GAW17 individuals were ascertained
from three major ethnic groups: (a) European origin
(European Americans [CEPH], Tuscan); (b) Asian des-
cent (Denver Chinese, Han Chinese, Japanese); and (c)
African ancestry (Yoruba and Luhya). Population strati-
fication analysis revealed separate clusters for these
major ethnic groups (data not shown). To avoid pro-
blems arising from stratification, we thus performed
GRANVIL analyses for each ethnic group separately and
combined the results for each gene using inverse-var-
iance fixed-effects meta-analysis of the parameter l,
implemented in the GWAMA software [10].
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error rates and power, we randomly removed rare var-
iant genotypes from individuals to simulate missing
data. We considered a range of missing data rates: 0.1%,
0.5%, 1%, 5%, and 10% of all available genotypes. To
take account of the possibility of allele-specific failure
rates, we also considered a more complex model in
which heterozygous and rare homozygous genotypes
were more difficult to call. Specifically, we randomly
removed 1% of common homozygous genotypes, 5% of
heterozygous genotypes, and 10% of rare homozygous
genotypes. For each model of missing genotype data, we
generated 1,000 replicates of data, each from a randomly
selected phenotype file from GAW17.
The power (type I error rate) was assessed at a nom-
inal Bonferroni-corrected threshold of p ≤ 3.86 × 10
−5
(0.05/1,297 genes having at least two rare variants). We
assessed power by considering all genes known to be
causal for the respective phenotype and calculated type I
error rate by considering all noncausal genes [8].
Results
Analysis of all rare variants and analysis of only nonsy-
nonymous rare variants generated qualitatively similar
results. We thus present here the results for the analysis
of nonsynonymous variants.
Despite the simulated rate of missing genotype data,
we were able to detect the association of the causal
FLT1 gene with Q1 in 100% of the runs (Figure 1). The
causal KDR gene was detected in 23.2% of replicates
with a 90% random call rate, in 23.8% of replicates for
our allele-specific model, and in 26.8% of replicates
when there was no missing genotype data. For the rest
of the causal genes for Q1, we had low power to detect
associations with ARNT (up to 3.9% of replicates,
depending on the call rate) and HIF1A (0.5% of repli-
cates with a 90% random call rate, 0.6% with a 95% ran-
dom call rate, and just 0.3% with our allele-specific
model). Interestingly, the power of HIF1A was lower in
our models with higher random call rates, although this
is likely to reflect stochastic variation in our simulations.
The type I error rate for the detection of association
with Q1 was higher than expected in several noncausal
genes, including OR2T34, OR2T3, NOMO1, and HLA-B.
The high type I error rates remained, irrespective of the
call rate; for example, association with OR2T34 was
detected in 78.4% of replicates for a 90% random call
rate and increased to 85.9% of replicates when there
were no missing data. Thus these type I errors have not
occurred as a result of missing genotypes but because of
extended linkage disequilibrium between rare variants
across chromosomes.
For Q2, we had power to detect association with sev-
eral causal genes, namely, BCHE, LPL, SIRT1, SREBF1,
and VLDRL, but only in a small percentage of replicates
(up to 4.2% with a 99% call rate) (Figure 2). The type I
error rates for Q2 were lower than those for Q1. For
Q4, which is not associated with variants in any gene,
t h ef a l s e - p o s i t i v ee r r o rr a t ew a sn e v e rh i g h e rt h a n1 . 1 %
(Figure 3).
For the disease (CC) phenotype, we were able to
detect the causal FLT1 gene locus in 5% of replicates
with no missing genotype data, 5.3% of replicates with a
99.9% call rate and the allele-specific model, and only
1.6% of replicates with a 90% random call rate. The sec-
ond-ranked causal gene was PIK3C3,i d e n t i f i e di nj u s t
1.7% of replicates with no missing genotype data (Figure
4). In addition, the false-positive OR2T3 and OR2T34
Figure 1 Power to detect associations for Q1 phenotype using nonsynonymous markers. All gene regions affecting Q1 phenotype are
presented.
Mägi et al. BMC Proceedings 2011, 5(Suppl 9):S107
http://www.biomedcentral.com/1753-6561/5/S9/S107
Page 3 of 6genes, which showed associations with the Q1 pheno-
type, showed associations in 1.1% and 1.0%, respectively,
of the runs with the full data set accordingly.
Discussion
One of the key advantages of testing for association of
the mutational load within a gene is that we can take
account of multiple rare variants simultaneously [7].
Our results demonstrate that we have high power to
detect association with rare variants in some of the cau-
sal genes for Q1, Q2, and the disease (CC) phenotype.
Furthermore, our results sug g e s tt h a tm i s s i n gg e n o t y p e
data, with call rates as low as 90%, have little effect on
power. The mutational load association analysis imple-
mented in GRANVIL weights the contribution of each
individual to take account of missing genotypes. Our
Figure 2 Power to detect associations for Q2 phenotype using nonsynonymous markers. All gene regions affecting Q2 phenotype are
presented.
Figure 3 False-positive associations for Q4 phenotype using nonsynonymous markers. The ten most associated gene regions are
presented.
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low as 90%. There was evidence of increased type I
error rates for several noncausal genes, particularly for
Q1. However, this reflects long-range linkage disequili-
brium between rare variants rather than sensitivity to
missing genotype data.
We considered two models of missing genotype data:
random failure and an allele-specific model that gives
greater probability to uncalled heterozygous and rare
homozygous genotypes. Our results were consistent
across these two models. This is presumably because for
rare variants most of the genotypes are common homo-
zygotes and are thus more robust to call rates deter-
mined by the presence of a minor allele.
In this paper, we considered the effect of missing gen-
otype data on the power and type I error rates of a
method that tests for association of the mutational load
of rare variants within genes. However, sequence and
genotyping errors also play an important role in the per-
formance of any association approach for common or
rare variants. Analysis of the pilot data from the 1000
Genomes Project suggests greater concordance with
HapMap for common homozygous genotypes (more
than 99%) than for heterozygous or rare homozygous
genotypes (95–98%). The simulated GAW17 data could
also be used to assess the effect of a range of sequencing
and genotyping error models on the performance of rare
variant mutational load analyses.
Conclusions
The results of our analysis of the simulated GAW17
data suggest that the GRANVIL approach for testing
association with the mutational load of rare variants
within a gene is relatively robust to missing genotype
data, occurring either at random or with differential
allele-specific failures. Our power to detect association
with causal genes was not dramatically affected by call
rate. Similarly, the type I error rate for noncausal
genes is relatively unaffected by the rate of missing
genotypes but is somewhat inflated by the extent of
long-range linkage disequilibrium between noncausal
genes.
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